Lyra Therapeutics Stock Market Value
| LYRA Stock | USD 0.21 0.02 10.53% |
| Symbol | Lyra |
Lyra Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lyra Therapeutics. If investors know Lyra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lyra Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.49) | Revenue Per Share 0.023 | Quarterly Revenue Growth (0.64) | Return On Assets (0.42) | Return On Equity (1.86) |
The market value of Lyra Therapeutics is measured differently than its book value, which is the value of Lyra that is recorded on the company's balance sheet. Investors also form their own opinion of Lyra Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Lyra Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lyra Therapeutics' market value can be influenced by many factors that don't directly affect Lyra Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lyra Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Lyra Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lyra Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Lyra Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Lyra Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Lyra Therapeutics.
| 12/07/2023 |
| 12/01/2024 |
If you would invest 0.00 in Lyra Therapeutics on December 7, 2023 and sell it all today you would earn a total of 0.00 from holding Lyra Therapeutics or generate 0.0% return on investment in Lyra Therapeutics over 360 days. Lyra Therapeutics is related to or competes with CytomX Therapeutics, Assembly Biosciences, Achilles Therapeutics, Instil Bio, NextCure, Spero Therapeutics, and Nuvation Bio. Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of nove... More
Lyra Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Lyra Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Lyra Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 41.07 | |||
| Value At Risk | (10.00) | |||
| Potential Upside | 10.53 |
Lyra Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Lyra Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Lyra Therapeutics' standard deviation. In reality, there are many statistical measures that can use Lyra Therapeutics historical prices to predict the future Lyra Therapeutics' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.60) | |||
| Total Risk Alpha | (1.51) | |||
| Treynor Ratio | (0.31) |
Lyra Therapeutics Backtested Returns
Lyra Therapeutics has Sharpe Ratio of -0.0507, which conveys that the firm had a -0.0507% return per unit of risk over the last 3 months. Lyra Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Lyra Therapeutics' Risk Adjusted Performance of (0.04), standard deviation of 6.49, and Mean Deviation of 4.22 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.36, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Lyra Therapeutics will likely underperform. At this point, Lyra Therapeutics has a negative expected return of -0.33%. Please make sure to verify Lyra Therapeutics' skewness, as well as the relationship between the rate of daily change and price action indicator , to decide if Lyra Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.46 |
Average predictability
Lyra Therapeutics has average predictability. Overlapping area represents the amount of predictability between Lyra Therapeutics time series from 7th of December 2023 to 4th of June 2024 and 4th of June 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Lyra Therapeutics price movement. The serial correlation of 0.46 indicates that about 46.0% of current Lyra Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.46 | |
| Spearman Rank Test | 0.27 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Lyra Therapeutics lagged returns against current returns
Autocorrelation, which is Lyra Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Lyra Therapeutics' stock expected returns. We can calculate the autocorrelation of Lyra Therapeutics returns to help us make a trade decision. For example, suppose you find that Lyra Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Lyra Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Lyra Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Lyra Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Lyra Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Lyra Therapeutics Lagged Returns
When evaluating Lyra Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Lyra Therapeutics stock have on its future price. Lyra Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Lyra Therapeutics autocorrelation shows the relationship between Lyra Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Lyra Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Lyra Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Lyra Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Lyra Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Lyra Therapeutics Stock:Check out Lyra Therapeutics Correlation, Lyra Therapeutics Volatility and Lyra Therapeutics Alpha and Beta module to complement your research on Lyra Therapeutics. For information on how to trade Lyra Stock refer to our How to Trade Lyra Stock guide.You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Lyra Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.